{"answer":"Cardiome touts heart drug trial data Canada's Cardiome Pharma says that a Phase III trial of RSD1235 shows it was effective in restoring normal heart rhythm to 52 percent of patients suffering atrial fibrillation compared to 4 percent PLA-TAK-00020531 Source: https://www.indup50 80boosts.ucsf.edu/docs/ptjf0226 "}